Skip to main content
Figure 4 | BMC Neuroscience

Figure 4

From: Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function

Figure 4

MPs in the different clinical forms of MS. Comparison of PMP (A), EMPs-CD31 (B) and EMPs-CD62E (C) counts in healthy controls (Ct) and patients with CIS or MS. (*p < 0.05, **p < 0.01, ***p < 0.001 vs. healthy controls). CIS, clinically isolated syndrome. RRMS, relapsing, remitting MS. SPMS, secondary progressive MS. PPMS, primary progressive MS. Differences between pairs were assessed by Student’s t-test. MPs concentrations were not able to discriminate between the different clinical forms of MS (ANOVA). Numerical data and results of statistical analysis are shown in Table 2.

Back to article page